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Aim: To assess cell death pathways in response to magnetic hyperthermia. Materials 
& methods: Human melanoma cells were loaded with citric acid-coated iron-oxide 
nanoparticles, and subjected to a time-varying magnetic field. Pathways were 
monitored in vitro in suspensions and in situ in monolayers using fluorophores to 
report on early-stage apoptosis and late-stage apoptosis and/or necrosis. Results: 
Delayed-onset effects were observed, with a rate and extent proportional to the 
thermal-load-per-cell. At moderate loads, membranal internal-to-external lipid 
exchange preceded rupture and death by a few hours (the timeline varying cell-
to-cell), without any measurable change in the local environment temperature. 
Conclusion: Our observations support the proposition that intracellular heating may 
be a viable, controllable and nonaggressive in vivo treatment for human pathological 
conditions.
First draft submitted: 01 August 2015; Article accepted for publication: 12 October 2015; 
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Over the last decade the possible therapeutic 
use of heat generated in magnetic nanopar-
ticles by time-varying magnetic fields, viz. 
magnetic field hyperthermia (MFH), has 
been a subject of great interest in both the 
scientific and medical research communi-
ties [1–4]. The underlying principle is attrac-
tive and straightforward: that cancer cells are 
sensitive to elevated temperatures, and that 
in vivo treatments can utilize targeted mag-
netic nanoparticles to transform hysteretic 
energy losses, induced by the time-varying 
field, into a localized source of heat.
However, there is a significant issue with 
current translational research efforts in mag-
netic hyperthermia, in that the nature of the 
cell death pathways – as opposed to outcomes 
– that are triggered by MFH have until now
been unclear. This is because almost all previ-
ously reported in vitro and/or ex vivo assays
have relied exclusively on post hoc assessments
of cell viability or morphology, as determined 
after the application of the time-varying 
field [5–11]. To our knowledge, the only excep-
tion to this rule, to date, was a very recent 
publication on real-time imaging of MFH 
experiments using a confocal microscope [12] 
– albeit that the focus of that work was on
the immediate consequences of the MFH
during treatment, and on lysosome mem-
brane permeabilization events, rather than
on longer term consequences to the cell as a
whole. Furthermore, in vivo measurements of
cellular function at the necessary subcellular
length scale, and over the requisite period of
time both during and after the application
of the time-varying field, are not feasible in
any approvable preclinical study. As such, the
cell death pathways have remained an open
question.
This issue is potentially a significant 
impediment in the clinical exploration of 
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MFH, given that national health authorities and regu-
lators around the world are almost always concerned to 
understand the ‘primary mode of action’ of any given 
intervention. In the case of MFH, this translates into 
a demand for a comprehensive model, at the cellular 
and subcellular level, of how the localized generation of 
heat affects the tissue and fluid environment in which 
the magnetic particles reside. In particular, there are 
fundamental questions to be answered as to whether 
the primary mode of action is a purely physical one, 
or one that involves an induced biological response. 
In many countries this can determine whether or not 
the intervention is classified as that of a medical device 
(e.g., in the case of a physical mode of action), or that 
of a drug (e.g., in the case of a biological mode of 
action involving an induced metabolic, immunological 
or pharmacological action). The device or drug clas-
sification, in turn, can have major ramifications as to 
the cost and length of time that it may take to get a 
new therapeutic into clinical practice, and available to 
patients.
It is with this issue in mind that we have, over the last 
3 years, developed a real-time in situ molecular track-
ing system specifically for explorations of the cell death 
pathways (and therefore modes of action) for controlled 
in vitro cell cultures in the presence of MFH-inducing 
magnetic fields. This has involved both the develop-
ment of the requisite instrumentation, viz. a specially 
engineered magnetic field appliance incorporated into 
a fluorescent/optical live-cell imaging microscope, 
and the development of an imaging protocol capable 
of delivering substantive information on cell death 
pathways. Although another group has independently 
been working on combined MFH/microscope instru-
mentation [12], we report here, for the first time, on a 
complete system of both instrumentation and imaging 
protocol for the purpose of understanding the primary 
modes of action of magnetic hyperthermia. We take, 
as a paradigmatic exemplar, the action of MFH on the 
DX3 human melanoma cell line.
Melanoma is an aggressive disease that accounts 
for ca. 4% of all deaths by cancer, and nearly 80% of 
the ones related to skin cancer, with a 5-year survival 
expectancy of ca. 14% [13]. The initial post diagnosis 
treatment is usually surgical removal, but the inva-
sive nature of melanoma often necessitates further 
treatment to ensure eradication and limit recurrence. 
Understandably, then, there is a clinical drive towards 
finding better and improved interventions to treat mel-
anoma, and MFH, either as a stand-alone treatment 
or in conjunction with anticancer drugs, is one of the 
methods that is being explored.
Recent preclinical studies on MFH treatment 
of murine melanoma have shown encouraging 
results [14–18]. However, the control over the treat-
ment intensity was rather limited, frequently leading 
to tissue necrosis, with the associated possible side 
effects that necrosis brings (such as vascular disrup-
tion and scarring), as well as the subsequent need for 
surgical removal of the dead tissue. It would clearly 
be preferable to move towards less aggressive apop-
totic cell death pathways, but to do so it is imperative 
to distinguish between the two pathways and relate 
them to the dose–response characteristic of the MFH 
treatment.
To this end we have built and used a bespoke real-
time in situ MFH imaging system to explore the apop-
totic and/or necrotic cell death pathways exhibited 
by DX3 human melanoma cells inoculated with iron 
oxide nanoparticles in response to the application of 
time-varying magnetic fields. Prior to heating, the 
DX3 cells were loaded with citric acid-coated iron 
oxide nanoparticles to a concentration ranging from 
ca. 210 to 400 pg of iron oxide per cell, which was 
found to be sufficient to deliver intracellular hyper-
thermia in response to a time-varying magnetic field, 
but not so high as to affect the viability of the cells 
under normal (zero field) conditions. The nanopar-
ticles were specifically chosen to be ones that exhibited 
excellent magnetic heating properties, with an intrin-
sic loss parameter of 4.1 nHm2kg-1 [19]. To monitor 
the cell death pathways, two fluorescent markers were 
used: (i) Annexin V-FITC for early-stage apoptosis, 
a pseudogreen-colored membrane stain activated by 
internal-to-external lipid exchange in the cell mem-
brane; and (ii) either DRAQ7 or propidium iodide 
(PI) for late-stage apoptosis or necrosis, both of which 
are pseudored-colored nuclear stains that cannot 
penetrate intact membranes.
Cell death pathway experiments were performed 
under a selection of different conditions. In one 
experiment of particular note, when the cells were 
subjected to MFH at a level of ca. 145 nW per cell for 2 
h, clear evidence of delayed-onset apoptosis was seen. 
In this case, all of the cells in the culture remained 
viable for 1 h after the MFH was applied, but then 
one-by-one the cells started to die, until, after a fur-
ther 18 h had elapsed, all the cells were dead. Control 
experiments were performed to rule out the possibil-
ity that this might be a bystander effect, indicating 
that this is indeed a hitherto unknown effect. It is 
hoped that MFH-induced delayed-onset apoptosis 
may be of significant clinical interest, given the like-
lihood that the idiopathic burden on healthy tissue 
associated with such a treatment will be much less 
than that involved with traditional heat-based thera-
pies based on microwave or radiofrequency radiation 
or ultrasound.
www.futuremedicine.com 123future science group
Real-time tracking of delayed-onset cellular apoptosis induced by intracellular magnetic hyperthermia    Research Article
Materials & methods
Microwave-assisted synthesis of citric acid-
coated iron oxide nanoparticles
Unless otherwise stated, all reagents were obtained 
from Sigma Aldrich, UK, and used as received. 
The synthesis route was the same as was previously 
reported in [19] for the sample identified therein as 
‘CA-ioH’.
Citric acid-coated iron oxide nanoparticles (CA-
IONPs) were made by co-precipitation of ferric and 
ferrous chloride salts with sodium carbonate and post 
precipitation addition of a citric acid solution, with the 
aid of a SP-Discovery Microwave oven (CEM Corpora-
tion, USA). Briefly, a solution of FeCl
2
.4H
2
O (0.02 M, 
where M denotes molarity, i.e., 0.02 M = 0.02 mol/l) 
and FeCl
3
.6H
2
O (0.04 M) was transferred into a vial 
and sealed with a pressure cap. The solution was heated 
to 60°C (microwave power setting 300 W) and sodium 
carbonate aqueous solution (1 M) was added with a 
syringe pump (2 ml/min) (World Precision Instru-
ments, UK). The solution was kept at 60°C for 10 min 
and then citric acid solution (2 mmol, 1 ml ddH
2
O) 
was added. The solution was then maintained at 60°C 
for a further 10 min. The obtained nanoparticles were 
then washed by magnetic separation and redispersed 
in ddH
2
O.
The magnetic heating properties of the as-made 
CA-IONPs were determined using standard methods 
for nonadiabatic test conditions [20], and quantified 
in terms of the intrinsic loss parameter (ILP) of the 
particles.
Cell culture & magnetic nanoparticle loading
DX3 human melanoma cells were obtained from the 
Barts Cancer Institute, Queen Mary University of 
London. Adherent cells were cultured in high glucose 
Dulbecco’s Modified Eagle Medium (DMEM) con-
taining 10% fetal calf serum (FCS), 1% penicillin and 
1% stable L-glutamine (complete DMEM) [21]. Cells 
were incubated at 37°C and 8.5% CO
2
. The culture 
medium was changed every other day and the cells 
passaged every 5 days.
Initially, 2 × 107cells were cultured prior to starv-
ing using FCS-free complete DMEM to induce sub-
sequent uptake of CA-IONPs. After 12 h, the cells 
were fed with complete DMEM including 0.5 mg/ml 
of CA-IONPs and returned to culture for 12 h. After-
wards, the cell flasks were rinsed five-times with pre-
warmed (37°C) phosphate buffered saline (PBS) prior 
to harvesting.
DX3 cells were harvested with Accutase [22,23], 
washed twice with prewarmed PBS by centrifugation 
(1100 rpm, 10 min, 4°C) and fixed (3.5% paraformal-
dehyde and 2% sucrose in PBS) for 10 min at room 
temperature. The obtained cell pellet was washed 
twice by centrifugation (1100 rpm, 10 min, 4°C) with 
ddH
2
O. The number concentration of cells in the final 
cell suspension was counted by flow cytometry (Accuri 
C6, BD Biosciences).
The internalized nanoparticles were quantified using 
a superconducting quantum interference device vibrat-
ing sample magnetometer (SQUID-VSM, Quantum 
Design, USA) by recording a room temperature mag-
netization curve, and comparing the measured satura-
tion magnetization to that obtained from a calibration 
sample of neat CA-IONPs at a known concentration. 
The measured concentration of particles was combined 
with the measured number concentration of cells in 
the sample to estimate the average mass concentration 
of CA-IONPs per cell.
Histology & localization studies
DX3 human melanoma cells were cultured on glass 
coverslips in a 24-well plate at 5 × 104 cells/well and 
cultured for 24 h prior to loading. Cells were starved, 
loaded with magnetic particles and fixed, as described 
above. Cells were stained for iron content with Prus-
sian Blue (1:1 4% HCl : 4% K
4
Fe(CN)
6
, 10 min, two-
times), rinsed with ddH
2
O and counterstained with 
nuclear fast red (2 min). Stained cells were dehydrated 
with ascending alcohols by immersion in 70% etha-
nol (2 min), 100% ethanol (1 min, two-times) and 
xylene (10 min) and mounted. The cells were assessed 
by light microscopy using an inverted microscope 
(DMI6000B, Leica, UK).
In vitro MFH treatment on cell suspensions
DX3 cells were cultured and loaded with particles as 
described above, then harvested with Accutase and 
resuspended (1 × 106 cells/ml) in phenol-red-free 
complete DMEM media containing 25 mM HEPES. 
They were then loaded into 1.5 ml Eppendorf tubes 
and placed in a controlled alternating magnetic field 
supplied by a desktop solenoid-based Magnetic Alter-
nating Current Hyperthermia system (MACH system, 
Resonant Circuits Ltd, UK). This system comprised a 
six-turn water-cooled solenoid coil capable of deliver-
ing a magnetic field with near-uniform (within ± 6%) 
intensity over a cylindrical volume of height ca. 16 mm 
and diameter ca. 20 mm at the center of the solenoid 
(Supplementary Information S1).
Time varying magnetic fields of amplitude 6.6, 10.5, 
12.0, 14.7 and 16.1 kA/m were applied at a constant 
frequency of either 911 or 950 kHz, for a total treat-
ment period of 2 h per sample. Aliquots were taken 
for analysis before, during and immediately after the 
hyperthermia treatment (i.e., at t = 0, 1 and 2 h). After 
treatment, half of the remaining cells were transferred 
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to culture plates and incubated for 2 days, with their 
viability being assessed at t = 24 and 48 h. The other 
half of the cells were kept in their Eppendorf tubes, 
and their viability assessed at t = 5 h. Control experi-
ments were carried out under each of the hyperthermia 
experimental conditions (i.e., for each of the six time 
points and for each of the five field and frequency con-
ditions), using native (not magnetically loaded) DX3 
cells.
Wherever possible, both before and during the 
experiments, the cells were kept at 37°C in buffered 
media to maintain incubation ambient conditions, 
and in the dark to minimize light impact reducing cell 
damage from light exposure. During the hyperthermia 
treatment, the temperature of the cell culture medium 
was monitored using a Luxtron FOT fluoroptic probe 
thermometer (LumaSense Technologies, USA). A 
mounting device was used to ensure that the thermom-
eter tip was placed at the same position in the Eppen-
dorf tubes each time, to allow for direct comparison 
between the different experiments.
In situ MFH treatment on cell monolayers
DX3 cells were seeded on a 35-mm Fluorodish cell 
culture dish (World Precision Instruments, USA) 
with a working window of 10 mm, at 4 × 105 cells/
well. Cell loading was carried out as previously stated. 
After incubation, the cell layer was washed two-times 
with prewarmed PBS (37°C). The wells were supple-
mented with fresh phenol-red-free complete DMEM 
media containing 25 mM HEPES, and the cells were 
then stained for live imaging with Annexin V-FITC 
and DRAQ7 [24] (1 μl/100 μl media) (BD Biosci-
ences, UK). Cell dishes were kept in darkness before 
being and transferred to a live-cell-imaging inverted 
microscope (DM1600B, Leica, UK) equipped with a 
Pecon BL-TIRF incubation chamber and an Insert P 
microscope stage heater and cover (Leica, UK) and a 
bespoke MACH system (Resonant Circuits Ltd, UK). 
The Insert P microscope stage was modified using 
replacement plastic parts in place of the metal parts 
that would otherwise have been subject to nonspecific 
eddy-current heating from the MACH system.
The bespoke ‘pancake’ geometry MACH system 
was specifically designed by Resonant Circuits Ltd for 
in situ operation in the live-cell-imaging microscope 
(Supplementary Information S2). It featured a five-
turn drive coil made from 2-mm diameter copper pipe 
wound into a flat spiral with 0.5-mm spacing between 
turns, and inner and outer diameters of 15 and 44 mm. 
The coil was mounted in the microscope, ca. 5 mm 
above the tissue culture dish, and aligned so that the 
cells were viewable through the center of the coil. A 
bespoke nonmetallic baseplate was made to incorpo-
rate both the coil and the culture dish within the CO
2
-
controlled incubation chamber. The entire micro-
scope, including the pancake-MACH system, was set 
within a temperature-controlled chamber, which was 
set to 37°C throughout the MFH treatment, and the 
subsequent post treatment imaging.
The cells were allowed to equilibrate for 1 h in the 
chamber before they were subjected to a time-varying 
magnetic field of amplitude 10.5 kA/m and frequency 
of 950 kHz for 2 h. Cells were kept in the incubation 
chamber at 8.5% CO
2
 and imaged in situ for 24 h. 
Time-lapse images were captured hourly using three 
channels: phase contrast, far-red fluorescence (CY5; 
excitation/emission wavelengths = 647/670 nm) and 
green fluorescence (FITC; 495/ 519 nm).
Nanoparticle cytotoxicity & cell viability
Nanoparticle cytotoxicity was studied with a ‘cell 
counting kit 8’ (NBS Biologicals, UK), used as stated 
by the manufacturer. DX3 cells were seeded on a 
96-well-plate (1 × 104 cells/well) and returned to cul-
ture. Cell loading was carried out as previously stated 
at concentrations ranging from 0–0.5 mg/ml. Cells 
were rinsed (five-times) with prewarmed PBS (37°C) 
to remove any free iron oxide nanoparticles and sup-
plemented with complete phenol-red-free DMEM 
medium and the WTS8 solution. Cells were returned 
to culture for 2 h and the absorbance measured at 
450 nm (SpectraMax M2e, Molecular Devices, UK). 
A positive control for cell toxicity was provided with 
10% NaN
3
.
Cell viability before, during and after the in vitro 
hyperthermia treatments on cell suspensions was 
assessed using a FITC-Annexin V Apoptosis Detection 
Kit (BD Pharmingen, BD Biosciences, UK); propid-
ium iodide solution was included in the same kit. Ali-
quot cell suspensions (ca. 105 cells) were taken at time 
points t = 0, 1, 2, 5, 24 and 48 h, as described above. 
Cells were stained before analysis by flow cytometry 
(Accuri C6 Flow Cytometer, BD Biosciences, UK).
Cell viability before and during the in situ hyper-
thermia treatment on cell monolayers was assessed 
using both Annexin V-FITC (green) and DRAQ7 (far-
red) stains (at 1 μl stain per 100 μl media) (BD Biosci-
ences, UK). Fluorescence images were captured every 
hour for 24 h, starting from immediately before the 
cells received 2-h exposure to the alternating magnetic 
field. The imaged region, which covered ca. 230 μm × 
300 μm of the plate, was kept constant throughout to 
enable longitudinal tracking of individual cells.
Results
In this study, citric acid-coated iron oxide nanopar-
ticles (CA-IONPs) were used to deliver intracellular 
www.futuremedicine.com 125
Figure 1. Magnetic nanoparticle internalization in DX3 human melanoma cells. (A) Transmission electron 
microscopy image of the as-made citric acid-coated iron oxide nanoparticles (CA-IONPs) used in this study. A 
magnified view is shown in the inset. (B) Bright field image of DX3 human melanoma cells loaded with the CA-
IONPs stained with Prussian blue and counterstained with nuclear fast red. The ring-like perinuclear iron staining 
(arrowed) seen around the cell nucleus indicates intracellular uptake. (C) Representative transmission electron 
microscopy image of a DX3 cell loaded with CA-IONPs. 
IP: Internalized nanoparticles in endosomes; N: Nucleus. 
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heating to DX3 human melanoma cells. The particles 
were synthesized by co-precipitation of ferric and fer-
rous chloride salts, with sodium carbonate, in a micro-
wave reactor [19]. Subsequently, citric acid was added 
to the solution to provide a surface coating with good 
biocompatibility, transport and cellular internalization 
properties [25–28]. The particular CA-IONPs chosen 
here were optimized for their magnetic heating prop-
erties. Their measured intrinsic loss parameter (ILP 
≈ 4.1 nHm2kg-1 [19]) is comparable to that of the best 
superparamagnetic heating materials reported to date 
(Supplementary Information S3).
Transmission electron microscopy (TEM) analy-
sis showed that the CA-IONPs were multicore 
particles with a mean core diameter of 17 ± 3 nm 
(Figure 1A & Supplementary Information S4). Dynamic 
light scattering analysis indicated that the CA-IONPs 
had a mean hydrodynamic diameter of ca. 66 nm – 
substantially more than the 17 nm core diameter 
measured by TEM, and consistent with the particles 
being multicore in their nature. From these two mea-
surements the mean number of cores per particle was 
estimated to be N ≈ 35, assuming a loose random pack-
ing of the constituent core particles, with a 60% v/v 
content [19].
Histology data on the CA-IONP-incubated DX3 
cells showed that their morphology was not affected 
by the presence of the nanoparticles, and cytotoxicity 
studies showed that even after 12 h of incubation with 
0.5 mg/ml of CA-IONPs there were no significant 
effects on cell viability (Student’s t-test, two-tailed, 
p > 0.05) (Supplementary Information S5). Following 
Prussian blue and nuclear fast red staining, optical 
microscopy of the incubated cells showed ring-like par-
ticle agglomerations in some images (Figure 1B), con-
sistent with intracellular uptake of the nanoparticles 
and their subsequent arrangement in the cytoplasm, 
and exclusion from the cell nucleus. The highest mag-
nification TEM images (Figure 1C) confirmed this 
assessment by revealing discrete clusters of nanopar-
ticles at subcellular length scales, as is typical of the 
presence of internalized nanoparticles in endosomes or 
similar vesicles.
Cytometer and magnetometer data indicated that 
when incubated for 12 h with the 0.5 mg/ml prepara-
tion of CA-IONPs, the DX3 cells took up and retained, 
on average, ca. 315 pg of iron oxide per cell, with the 
batch-to-batch variation ranging from 210 pg/cell up to 
400 pg/cell (Table 1 & Supplementary Information S6). 
These are relatively high levels of uptake, e.g. compared 
with the 60 pg/cell that was reported previously for the 
uptake of dextran-coated iron oxide nanoparticles in 
rabbit mesenchymal stem cells [29], and are indicative 
of the effectiveness of the citric acid coating in enhanc-
ing the internalization capacity of the particles, while 
still avoiding disruption to the cell’s viability.
In vitro MFH experiments on the CA-IONP-loaded 
cells were performed using a solenoid-based desktop 
MACH system, operating at the magnetic field inten-
sities and frequencies listed in Table 1. For each set of 
experiments at a given field and frequency setting, a 
fresh batch of cells was prepared. The resultant MFH-
induced thermal load in the cells was estimated from 
the measured concentration of particles per cell, and 
the known heating capacity of the particles: these gave 
rise to estimates for the load that ranged from ca. 35 
nW/cell up to ca. 390 nW/cell (Table 1). Control exper-
iments were performed on nonloaded cells at each of 
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the magnetic field intensities and frequencies, allowing 
direct comparison of the influence of the CA-IONPs 
on the cellular responses.
During the 2 h of MFH treatment, the tempera-
ture of the cellular suspension medium (which we 
shall refer to as the ‘local environment temperature’, 
T
local
) was monitored using a fluoroptic probe. In all 
cases the T
local
 temperature increased on application 
of the MFH, and reached a plateau after ca. 20 min 
that was sustained until the MFH field was removed 
(Supplementary Information S7). These measured T
local
 
temperatures are shown in Figure 2A for both the loaded 
and control cells. The data show nonspecific peripheral 
heating effects at the two highest magnetic field intensi-
ties, where in both cases the T
local
 temperatures in the 
controls exceeded 40°C. Such peripheral heating effects 
are well documented [20], and are an unavoidable con-
sequence of the heat generated by the currents flowing 
through the electromagnetic coil at these highest fields. 
However, it is also notable from Figure 2A that in all 
cases the T
local
 temperature recorded for the loaded cells 
was ca. 5–8°C higher than that in the control cells, 
indicating that the expected magnetic heating effect is 
indeed present. It is also notable that at the three high-
est thermal loadings (those exceeding 200 nW/cell) the 
T
local
 temperatures exceeded the 42°C benchmark that 
is widely considered to be a threshold for cellular dam-
age due to environmental heating [30].
The local environment heating effect was 
further explored by performing flow cytom-
etry experiments on the loaded and controls cells 
(Supplementary Information S8). Two fluorescent 
markers were used: green Annexin V fluorescein iso-
thiocyanate (FITC) as a marker of early-stage apop-
tosis, and red propidium iodide (PI) as a marker for 
later-stage apoptosis and/or necrosis. As shown in 
Figure 2B & C the percentage of the original cell popu-
lation that were still alive at time t = 2 h (immediately 
after the MFH treatment) and at t = 48 h showed simi-
lar trends as were seen with T
local
. At both timepoints 
the control cells remains almost 100% viable up to 
ca. 200 ng/cell thermal load, but showed significant 
cell death at higher loads. Meanwhile the CA-IONP-
loaded cells showed progressively increasing levels of 
cell death across the entire range of thermal loadings.
The morphological and structural integrity of the 
cells immediately following the MFH treatment was 
assessed by TEM (see Figure 3). Treatment under ther-
mal loads of 135 and 210 nW/cell did not affect the 
integrity of the cells (Figure 3A & B); however, the for-
mation of vacuoles in the cytoplasm at these MFH lev-
els are indicative signs of cellular apoptosis [31,32]. The 
size and number of the vacuoles increased with increas-
ing thermal load, with the additional appearance of cell 
blebbing, which is a characteristic of more advanced cel-
lular apoptosis [32–34]. Complete loss of cell membrane 
integrity with extreme damage to the internal structure 
of the cell was observed at higher thermal loads, as evi-
dent in the 390 nW/cell case shown in Figure 3C. Under 
these conditions, some of the cells were found to have 
swelled up, and the cytoplasm and all the organelles 
were disrupted, consistent with the cells having expe-
rienced a rapid and possibly violent process of necrosis 
and cell death at this elevated level of thermal loading.
Table 1. Parameters used for magnetic field hyperthermia experiments on citric acid-coated iron 
oxide nanoparticle-loaded DX3 melanoma cells.  
Mean loading mcell 
(pg of iron oxide 
per cell)
Coil currentI(A)† Field intensity H 
(kA/m)†
Frequency f (kHz)‡ Thermal load P  
(nW per cell)
In vitro experiments on cell suspensions
210 ± 10 50.4 ± 0.7 6.6 ± 0.1 950 35 ± 5
315 ± 15 80.2 ± 1.5 10.5 ± 0.2 950 135 ± 15
370 ± 20 91.6 ± 1.5 12.0 ± 0.2 950 210 ± 20
285 ± 15 112.2 ± 2.2 14.7 ± 0.3 911 230 ± 20
400 ± 20 122.9 ± 2.2 16.1 ± 0.3 911 390 ± 35
In situ experiment on cell monolayers
315 ± 75§ 80 ± 4 10.8 ± 0.5 950 145 ± 45
The mean magnetic nanoparticle loading per cell, m
cell
, determined by cytometer and magnetometer measurements; the peak current in the 
coil, I; the corresponding peak applied magnetic field intensity, H: the frequency of the applied field, f; the deduced mean thermal load, P = 
m
cell
 ILP H2 f, where ILP = 4.1 ± 0.1 nHm2kg-1 is the CA-IONP’s intrinsic loss parameter. 
†Both current and field intensity vary sinusoidally with time, with instantaneous values I sin(ωt+ϕ) and H sin(ωt+ϕ), respectively, where  
ω = 2πf, and ϕ is a constant.
‡Negligible error was determined on the generator frequency.
§Direct measurement of the loading was not possible for the in situ experiment, so the figure quoted is an estimate based on the mean and 
standard deviation of the loadings recorded in the in vitro experiments.
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Figure 2. In vitro magnetic field hyperthermia treatment effects in citric acid-coated iron oxide nanoparticle-
loaded DX3 melanoma cells (circles) and nonloaded controls (squares). (A) The local environment temperature 
Tlocal measured in the cell suspension medium during the course of the 2-h magnetic field hyperthermia treatment 
(this is the plateau temperature reached at t ≈ 15 min, and sustained until the treatment ceased at t = 2 h). (B) The 
percentage of the original cell population that were alive at time t = 2 h, immediately after the magnetic field 
hyperthermia treatment. (C) The percentage of the original cell population were alive at time t = 48 h. All data are 
plotted with respect to the mean thermal load per citric acid-coated iron oxide nanoparticle-loaded cell, P, which 
refers also to the respective field and frequency conditions employed, as listed in Table 1. Solid lines are guides to 
the eye only.
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The time-dependent nature of the effect on the DX3 
cells of the in vitro MFH treatments was analyzed by 
expanding the previously described flow cytometry 
measurements to include each individual timepoint 
and thermal load condition, and by separating out data 
on each sample population’s percentage of live cells, 
FITC-positive cells and PI-positive cells. These data 
are summarized in Figure 4, and provided in full in 
the Supplementary Information S8, for the CA-IONP-
loaded cells.
It is clear on inspection of Figure 4 that in all cases 
the effect on the cell populations extends beyond the 
initial 2 h of the MFH treatment. At the lowest loading 
of 35 nW/cell the live cell count was 85% at 2 h but fell 
to 50% at 48 h, while both the FITC- and PI-positive 
cells showed similar trends, starting from low levels at 
2 h (5–15%) and rising to moderate levels (30–40%) 
at 48 h. At moderate loadings, such as the 135 and 210 
nW/cell cases, similar trends were evident, albeit reach-
ing lower live cell counts (25%), and higher FITC- and 
PI-positive counts (60–70%), at 48 h. At the highest 
loading of 390 nW/cell the trends are more marked, 
with almost complete cell death (only 5% live cells) 
and almost all the cells (95%) registering both the 
FITC and PI markers. Across the series, in most cases 
(the exception being the 210 nW/cell case), the popula-
tion changes between the t = 24 and 48 h timepoints 
were relatively small, of order a few percent, implying 
that the effect of the MFH treatment was primarily 
active in the first 24 h post treatment.
At this point, it was apparent: (i) that the in vitro 
experimental data had established that MFH treat-
ments at thermal loadings of less than 200 nW/cell 
could be undertaken without risking any environ-
mental heating effects; (ii) that the majority of the 
time-dependent effects were observable within 24 h 
of the start of the MFH treatment; and (iii) that the 
combined use of an early-stage apoptosis (FITC) bio-
marker and a later-stage apoptosis and/or necrosis (PI) 
biomarker had shown some synchronicity in their rate 
of change, but that it was impossible to distinguish 
them on the basis of the flow cytometry data only. 
Therefore, to further explore the cell death pathway, 
an in situ MFH treatment experiment was performed 
using a hybrid live-cell imaging plus magnetic heat-
ing system, the latter featuring a bespoke 5-turn spiral 
pancake-coil MACH appliance.
For the in situ experiment it was necessary to seed 
the CA-IONP-loaded DX3 cells directly onto a cell 
culture dish, which meant that it was not possible to 
directly measure their magnetic loading. As such, the 
loading of the cells was estimated from the average and 
standard deviation of all the measurements made on 
previous batches (see Table 1), giving a value of 315 ± 
75 pg/cell. The applied magnetic field intensity was 
then adjusted to bring the anticipated thermal load 
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Figure 3. Cell damage after magnetic field hyperthermia treatment under varying field conditions. Representative 
transmission electron microscopy images of DX3 human melanoma cells after MFH treatment for 2 h (i.e., recorded 
at t = 2 h) with a magnetic field delivering an average thermal loading of (A) 135 nW/cell;  
(B) 210 nW/cell; and (C) 390 nW/cell. The arrows indicate the presence of vacuole formation due to cell apoptosis.  
N: Nucleus.
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below the 200 nW/cell level above which environmen-
tal heating might occur. A field of intensity 10.8 kA/m 
at a frequency of 950 kHz was chosen, corresponding 
to a thermal load of 145 ± 45 nW/cell.
Cellular responses were observed in real time by flu-
orescence microscopy using Annexin V-FITC to image 
early-stage apoptosis and DRAQ7 to image later-stage 
apoptosis and/or necrosis. DRAQ7 was used in prefer-
ence to PI as it is designed to be nontoxic, and there-
fore is better suited to prolonged exposure (in this case 
24 h) to a given cell culture [24]. The microscope field 
of view was kept fixed throughout the experiment, 
which enabled the identification and tracking of all the 
individual cells that were present in the ca. 230 μm 
× 300 μm imaged region. For the cases reported here 
this corresponded to 80 cells in the control experiment, 
and 65 cells in the active experiment. The data thus 
obtained are summarized in Figures 5 & 6, and in the 
Supplementary Information S9.
In Figure 5 some representative fluorescence micros-
copy images from the in situ MFH treatment experi-
ment on CA-IONP-loaded cells are shown. It was 
notable that no FITC- or DRAQ7-positive cells were 
observed either during or immediately after the 2 h 
of MFH treatment, and that the first fluorescence 
appeared at t = 3 h. Thereafter, both FITC (green) and 
DRAQ7 (red) fluorescence was seen in each individ-
ual cell, with, in some cases, the FITC and DRAQ7 
appearing at the same time, and, in the majority of 
the cases, the FITC appearing first, to be followed an 
hour or more later by the DRAQ7. Some cases of cell 
contraction and membrane blebbing were seen from 
t = 4 h onwards (Figure 5), both of which are char-
acteristic of morphological changes associated with 
apoptosis [33]. DRAQ7 fluorescence intensity was pre-
served throughout the experiments, but in some cases 
the FITC fluorescence faded, being more susceptible to 
photobleaching.
In Figure 6 the in situ experiment data is presented 
in a form reminiscent of a survivorship or mortality 
curve, in this case referring to the cell death pathways 
of the ensemble of imaged cells. It is clear on inspec-
tion of Figure 6 that most CA-IONP-loaded DX3 cells 
are dead (only 2 of 65 cells remaining alive) by t = 24 h, 
whereas the majority of the control cells (58 of 80 cells) 
were unaffected by the MFH treatment. From Figure 6 
one can also identify the timepoint at which 50% of 
the exposed cells had died, viz. at t
LD50
 = 11 h. In the 
control experiment, in 2/80 cells DRAQ7 was seen 
but not FITC, while in 16/80 cells FITC was seen 
but not DRAQ7. In contrast, in the CA-IONP-loaded 
cells, none were found to be DRAQ7-positive and 
FITC-negative, and only 2/65 were FITC-positive and 
DRAQ7-negative. By far the majority of cells, 61/65, 
were both FITC-positive and DRAQ7-positive.
For the CA-IONP-loaded cells that exhibited both 
fluorescent signals during the course of the experiment, 
the observed time delay (t
2
 – t
1
) between the appear-
ance of the FITC (at t
1
) and the later appearance of 
the DRAQ7 (at t
2
) was found to follow a reasonably 
smooth distribution, as shown in Figure 7. It is appar-
ent from these data that in the majority of cases (50/65) 
the late-apoptotic and/or necrotic DRAQ7 biomarker 
was seen within 3 h of the appearance of the early-
apoptotic FITC biomarker. Equally, it is clear that in 
some cells the transition from early to late-stage apop-
tosis and/or necrosis takes longer, with one showing a 
t
2
 – t
1
 delay of 9 h.
Although we do not at present have a theoretical 
model for the progression of MFH-initiated cell death 
in the DX3 cells, it is notable that the histogram in 
Figure 7 is reminiscent of a log-normal distribution. 
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Figure 4. In vitro magnetic field hyperthermia treatment effects in DX3 melanoma cells. Flow cytometry data on 
DX3 melanoma cells labeled with Annexin V-FITC (FITC: green – indicative of early-stage apoptosis) and propidium 
iodide (PI: red – indicative of late-stage apoptosis and/or necrosis) stains, as a function of time following the 
application of 2 h of magnetic field hyperthermia treatment (from t = 0 to 2 h) at the indicated heat loads. The 
data correspond to six time points before, during and after the magnetic field hyperthermia treatment, for five 
different thermal loads, and to the percentage of the cells counted that were live, FITC-positive (registering a 
green fluorescence) and PI-positive (registering a red fluorescence), respectively. Solid lines are guides to the eye 
only.
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For this reason we attempted a phenomenological fit to 
the data by treating the histogram as a point-by-point 
dataset at times t
2
 – t
1
 = 0.5, 1.5, … 9.5 h. The resultant 
fit is shown as the dashed line in Figure 7. The mean, 
standard deviation and mode values of this fit were of 
order 1.1, 1.0 and 1.2 h, respectively.
Discussion
The citric acid-coated iron oxide nanoparticles (CA-
IONPs) employed in this study were specifically cho-
sen because of their high intrinsic loss parameter (ILP 
≈ 4.1 nHm2kg-1) and their high level of uptake (210–
400 pg/cell) in our chosen DX3 human melanoma cell 
line. Taken together, these factors allowed us to explore 
a very broad range of intracellular thermal loads, from 
zero up to P ≈ 390 nW/cell. Furthermore, by character-
izing the thermal load per cell in this way – something 
that to our knowledge has not yet become standard 
practice – we were able to explore in detail the cellular 
responses in the system in a manner that lends itself 
to discussion of the dose–response characteristics of 
magnetic field hyperthermia.
Initial cell viability tests showed that despite the 
high levels of uptake, that CA-IONP-loaded DX3 
130 Nanomedicine (Lond.) (2016) 11(2)
Figure 5. Cell-by-cell real-time tracking of cell death pathways – fluorescence imaging. Fluorescence microscopy 
images of citric acid-coated iron oxide nanoparticle-loaded DX3 cells during and after 2 h of magnetic field 
hyperthermia treatment (from t = 0 to 2 h) with a magnetic field delivering ca. 145 nW/cell of thermal energy. 
Cells were labeled with Annexin V-FITC (green) and DRAQ7 (far-red), and images were recorded hourly. Scale bar 
is 50 μm in all images.
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cells remained viable, and that the nanoparticles were 
internalized into endosomes within the cells. Subse-
quent in vitro MFH experiments on both nonloaded 
and loaded cells in suspension, using a solenoid-based 
MACH system, showed three distinct phenomena. 
The first was a nonspecific peripheral heating of the 
suspension medium due to the large currents flowing in 
the electromagnetic coils. This led to an environmental 
heating effect that was apparent in the nonloaded con-
trol-cell suspensions at the two highest magnetic field 
intensities used (viz. at H = 14.7 and 16.1 kA/m, cor-
responding to peak currents I = 112 and 123 A, respec-
tively). Under these conditions, after 2 h of exposure to 
the environmental heating, the control cells exhibited 
significant rates of cell death (of order 20 and 35%, 
respectively). That said, under less extreme conditions 
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Figure 6. Cell-by-cell real-time tracking of cell death pathways – accumulated mortality curves. Representative mortality curves for 
control (nonloaded) and CA-IONP-loaded DX3 melanoma cells during and after 2 h of magnetic field hyperthermia treatment (from 
t = 0 to 2 h) with a magnetic field delivering ca. 145 nW/cell of thermal energy. Data acquired by tracking individual cells in an in situ 
magnetic field hyperthermia treatment system. Cells were labeled with Annexin V-FITC and DRAQ7 stains, indicative of early-stage 
apoptosis and of late-stage apoptosis and/or necrosis, respectively. 
CA-IONP: Citric acid-coated iron oxide nanoparticle.
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(viz. up to H = 12.0 kA/m, I = 92 A), no significant 
cell death at all was measured in the nonloaded cells.
The second effect observed in the in vitro experi-
ments was an MFH-specific direct heating due to 
the presence of the magnetic nanoparticles. This was 
apparent in the measured local-environment (cell-sus-
pension) temperature, T
local
, which in all cases was ca. 
5–8°C higher than in the control suspensions, as well 
as in the observed quasilinear correlation between T
local
 
and P. These are intriguing observations, as they imply 
that the magnetic heating of the iron oxide nanopar-
ticles is not being confined within endosomes, or even 
within cells, but rather that some degree of thermal 
equilibration is taking place throughout the suspension 
as a whole.
The third phenomenon seen in the in vitro data was 
that of delayed-onset cell death in the magnetically 
heated cells. This was evidenced by flow cytometry 
in combination with dual-marker fluorescent stain-
ing; the latter to identify both early-stage apoptosis 
(Annexin V-FITC: activated by internal-to-external 
lipid exchange in the cell membrane) and late-stage 
apoptosis or necrosis (propidium iodide: a nuclear 
stain that cannot penetrate intact membranes). Defi-
nite time-delayed response curves were seen in the data 
for the proportion of cells that remained alive, as well 
as for the proportion of cells that were either FTIC-
positive, or PI-positive, or both. At the two lowest ther-
mal loads (p = 35 and 135 nW/cell) the proportion of 
FITC-positive cells appeared to be measurably higher 
than the proportion of PI-positive cells across the 48-h 
monitoring period, but at higher thermal loads such 
differences were not so apparent. The implication 
is that at the lower thermal loads, the progression of 
cell death via early apoptosis (and internal-to-external 
lipid exchange in the cell membrane) through to late-
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Figure 7. Prolonged cell death instigated by 
magnetic field hyperthermia treatment of citric 
acid-coated iron oxide nanoparticle-loaded DX3 
melanoma cells. Histogram of the delay between 
the time of appearance of Annexin V-FITC and 
DRAQ7 fluorescence biomarkers in citric acid-coated 
iron oxide nanoparticle-loaded DX3 melanoma 
cells, after those cells had been subjected to 2 h of 
magnetic field hyperthermia treatment delivering 
ca. 145 nW/cell of thermal energy. Data acquired by 
tracking individual cells in an in situ magnetic field 
hyperthermia treatment system. The dashed line is a 
phenomenological log-normal distribution fit to the 
data.
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stage apoptosis and/or necrosis (that leaves the nucleus 
exposed as a result of membrane rupture) is sufficiently 
prolonged that it is measureable; while at the higher 
thermal loads the progression is faster, and the events 
cannot be separated. That said, it should be noted 
that although the in vitro data gives clear evidence for 
delayed-onset cell death, the evidence as to the cell 
death pathway is not so well determined, and is largely 
based on supposition.
For this reason, the in situ MFH experiments on 
DX3 cell monolayers were especially significant, in that 
they allowed the time-dependent cell death pathways 
of individual cells to be monitored and recorded. This 
cell-by-cell monitoring, and the accumulated mortal-
ity curves that were derived from observing 80 control 
cells and 65 magnetically loaded cells, provided defini-
tive evidence that the sequence of cell death was indeed 
as had been surmised previously, with membrane lipid 
exchange preceding the exposure of the cell nucleus by 
a matter of some hours.
However, before discussing the implications of these 
results, we should consider the differences observed 
between the in vitro and in situ experiments, and their 
origins. The DX3 human melanoma cell line we used 
is an adherent cell line that grows best under plated 
conditions with controlled nutrients and CO
2
 levels. 
As such, when the DX3 cells are removed from their 
culture plates and placed as a cell suspension in an 
Eppendorf tube for the in vitro experiments, they are 
likely to be in a stressed state, and therefore more sus-
ceptible to induced cell death following MFH treat-
ment. In this context it is therefore rather unexpected 
to note that in the in situ experiment, where the cells 
were in their adherent state, and where they were sub-
jected to a relatively low thermal load of 145 nW/cell, 
the level of DRAQ7-indicated cell death in both the 
control and loaded cells (7/80 and 61/65 after 24 h) 
was significantly higher than in the corresponding 
in vitro experiments.
One possible explanation for this is that there may 
have been nonspecific environmental heating in the 
culture plate medium caused by the proximity of the 
pancake-coil MACH system, which was operating at a 
peak current of 80 A. We consider this to be unlikely 
however, as the proximity of the cells to the coils in the 
two systems (ca. 5 mm to the pancake coil, ca. 8 mm 
to the solenoid, at closest approach) was similar, and 
no nonspecific heating had been seen in the in vitro 
experiment at comparable currents. Also, the live-cell 
imaging microscope was placed in a thermally regu-
lated 37°C chamber, which should have mitigated any 
such effects.
Another possibility is related to the continuous expo-
sure to the Annexin V-FITC and DRAQ7 fluorescent 
imaging dyes that the cell cultures were subjected to in 
situ, as compared with the just-prior-to-measurement 
addition of the dyes in vitro. It is well known that 
excited fluorophores generate radical oxygen species 
(ROS), which can react with cell components such as 
proteins or nucleic acids, leading to delayed-onset pho-
totoxicity [35,36]. This effect would be present in situ, but 
not in vitro (where the record of any fluorophore activa-
tion was imaged at the same time as any correspond-
ing ROS production). We saw some evidence that such 
effects were important when we used the automatic 
focusing feature and ‘z-stacking’ on the in situ imaging 
camera to find the best focal plane at each timepoint, 
and observed substantial cell death. Subsequently, when 
we undertook bright-field manual focusing under low-
level illumination at each timepoint, and used a narrow-
band filter to limit the radiation exposure of the cells, we 
observed significantly reduced mortality rates in both 
the control and loaded cells. That said, ROS-mediated 
phototoxicity relies on the fluorophores being activated, 
which requires that there be dead or dying cells in the 
culture to begin with. In the control experiments, this 
was not expected to be the case.
A third explanation is that our expectation that 
the in situ adherent cells should be in a less stressed, 
and therefore more resilient state compared with the 
in vitro nonadherent cells is not correct. This is cer-
tainly possible, as the cellular metabolism may well 
be different between the two environments. It is also 
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possible that the effect of the MFH treatment on the 
DX3 cells may be different for a cell monolayer com-
pared with a cell suspension, as in the latter case there 
might be more opportunities for the cells to dissipate 
heat by, for example, transforming the heat energy 
into mechanical energy via increased Brownian 
motion.
Consequently, in our estimation the observed dif-
ferences in cell viability in situ versus in vitro are 
most likely to be due to intrinsic differences in the 
cell metabolism and/or MFH response characteris-
tics in the experiments, possibly coupled to delayed-
onset ROS-mediated phototoxicity effects that would 
only be observable in situ. Despite this, we believe it 
is still valid and reliable to compare the results of the 
two experiments to understand better the effect of the 
MFH treatment on the cell death pathway.
Thus, returning to the in situ data, it is clear that 
the MFH treatment had a substantial effect, as evi-
denced by the near-total cell mortality it elicited, and 
also that it was definitively a delayed-onset effect, with 
a smooth progression of cell death proceeding over the 
24-h period of the experiment. Furthermore, in all 
cases the Annexin V-FITC dye was activated at a given 
cell’s membrane at the same time as, or before, the 
DRAQ7 dye was activated at the same cell’s nucleus. 
These are significant observations indicating that con-
trolled apoptosis-based rather than necrotic cell-death 
pathways may be achievable in vivo.
Another key observation relates to the evolution of 
the cell-by-cell responses observed in the in situ data, 
where the fluorescently activated cells appear one by one 
at randomly distributed sites on the plate. It is strik-
ing that there is no evidence here for any cooperative or 
intercellular effects. Indeed, given an expectation that 
there would be environmental (extracellular) heating 
effects associated with the MFH treatment, one would 
have expected to see the fluorescence progressively 
spreading out from a given cell to its neighbors and 
beyond, in a sequential manner. Instead, it very much 
appears to be a stochastic, individual cell effect. This 
leads to the consideration that these are cell-specific 
events, directly relating to the presence in a given cell of 
internalized magnetic nanoparticles, and the associated 
generation, under MFH treatment, of internalized heat.
This is very important for potential in vivo applica-
tions, where research teams around the world have been 
exploring strategies for surface-functionalising mag-
netic nanoparticles with targeting moieties such as anti-
bodies, antibody fragments, proteins and peptides, with 
the objective of achieving indication-specific uptake in 
certain cells (e.g., cancer cells) only, while precluding 
uptake into healthy cells. This strategy has distinct ben-
efits regarding the ease of administration (e.g., intersti-
tial or intravenous injection) and the potential limiting 
of side effects, but previously there had been little real 
evidence to support the proposition that MFH treat-
ment could be effective at the level of an individual cell. 
Indeed, theoretical work has been presented that has 
precluded the possibility of this being a viable strategy, 
on the basis that the heat generated in a single cell would 
not be enough to generate even a localized environmen-
tal heating of sufficient magnitude to bring about cell 
death [37]. It is therefore highly significant to have been 
able to gather direct evidence for intracellular effects 
resulting from the internalized generation of heat.
Conclusion
A series of controlled in vitro and in situ magnetic field 
hyperthermia treatment experiments have been per-
formed on DX3 human melanoma cell suspensions 
and monolayers. The effect of intracellular heating – 
achieved by loading the cells with nontoxic concentra-
tions of citric acid-coated iron oxide nanoparticles and 
subjecting them to a time-varying external magnetic 
field – has been studied with respect to the cell death 
pathways that might result from the treatment.
Conclusive evidence has been gathered that indi-
cates: (i) that delayed-onset cell death may be 
achieved, with data showing that after a 2-h MFH 
treatment, mortality events were still taking place up 
to 24 and 48 h later; (ii) that the extent and time-
course of the cell death over a population of cells can 
be proportionately controlled by varying the level of 
the administered thermal load, with higher loads elic-
iting faster and more complete cell mortalities; (iii) 
that at moderate thermal loads, cell death proceeded 
in an orderly fashion, with membranal internal-to-
external lipid exchange preceding rupture and death 
by a few hours, with the timeline varying from cell 
to cell; and (iv) that the cell death was due to intra-
cellular heating and did not depend on any heating 
effects in the local environment. Together these obser-
vations provide a body of evidence in support of the 
proposition that intracellular heating may be a viable 
means of achieving a controllable, nonaggressive, 
in vivo treatment modality for human pathological 
conditions such as cancer.
Looking ahead, it is clear that a great deal more work 
needs to be done to explore in detail the cellular nature 
of magnetic hyperthermia. To this end, and in the inter-
est of encouraging the sharing of tangible data that will 
allow cross-comparisons to be made between different 
experimental systems and designs, we recommend to 
our fellow researchers the adoption of three metrics that 
we have found to be useful here. These are: (i) the mean 
magnetic nanoparticle loading per cell (m
cell
, in pg/cell) 
and the corresponding mean thermal load per cell (P, 
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in nW/cell); (ii) the cell-by-cell accumulated mortality 
curve as obtained from in situ experiments, with the 
associated timepoint at which 50% of the exposed cells 
had died (t
LD50
, in hours); and (iii) the cell death path-
way histogram of time delay between early apoptosis and 
late-stage apoptosis or necrosis, as obtained from in situ 
experiments with appropriate fluorescent biomarkers. It 
is hoped that by adopting a standard practice around 
making measurements such as these, a definitive assess-
ment protocol may be developed that could amount to 
a dose–response characteristic for future magnetic field 
hyperthermia treatments.
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Executive summary
Objective
• To study the real-time cell death pathways in a model system both during and after its exposure to a time-
varying magnetic field, and thereby draw conclusions regarding the dose–response characteristics and the 
primary mode of action of the treatment.
Methods
• Citric acid-coated iron oxides nanoparticles (core diameter 17 nm) were synthesised and loaded into human 
DX3 melanoma cells at concentrations of 210–400 pg per cell.
• In vitro and in situ experiments were performed on cell suspensions and monolayers, respectively, wherein 
the cells received 2 h of magnetic hyperthermia treatment, delivering a thermal load per cell that ranged from 
35–390 nW/cell.
• Real-time monitoring (before, during and up to 48 h after the treatment) of the cell death pathways was 
undertaken via flow cytometry (for the suspensions) and fluorescence microscopy (for the monolayers), using 
fluorophores to report on early-stage apoptosis and on late-stage apoptosis and/or necrosis.
Results
• Magnetic hyperthermia caused delayed onset cell death, the rate and extent of which was proportional to the 
thermal load. Under certain conditions, mortality events were found to be still taking place even at 48 h after 
the treatment.
• At moderate loads (145 nW/cell), membranal internal-to-external lipid exchange preceded rupture and death 
by a few hours, with the timeline varying from cell to cell. At these loads, no heating effects were measured in 
the local environments of the cells.
• Analysis of the in situ fluorescence microscopy data provided an accumulated, cell-by-cell mortality curve, 
from which an estimate of the timepoint at which 50% of the exposed cells had died was obtained  
(tLD50 ≈ 11 h, for a thermal load of 145 nW/cell).
Conclusion
• It is important to consider the delayed-onset cell death pathways that are instigated by magnetic 
hyperthermia, and recognize that effects may not be fully evaluable until many hours after the treatment 
itself ends.
• Nonaggressive, targeted cell death is achievable via intracellular heating, with the advantage that a 
measurable dose–response characteristic may be determined, and a primary mode of action ascertained. As 
such, magnetic hyperthermia has a real prospect of being usable in future in vivo human treatments.
www.futuremedicine.com 135future science group
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